Unigene Laboratories, Inc. (OTCBB: UGNE) announced that an independent Data Monitoring Committee (DMC) has recommended that Novartis and its partner Nordic Bioscience proceed as planned with their ongoing oral calcitonin Phase III studies for osteoporosis and osteoarthritis.
More...New Interdisciplinary Approach To Treating Lower Back Pain Unveiled By MSU Researcher
Article Date: 10 Dec 2009
Using a branch of science that crosses disciplines to study complex problems, a Michigan State University researcher is introducing a new way to understand and treat lower back pain, a condition affecting more than 40 million Americans and costing billions of dollars each year.
More...Outpatient Disc Treatment Gives Long-Term Back Pain Relief
Article Date: 03 Dec 2009
A randomized, controlled study comparing standard conservative therapy to a minimally invasive treatment called percutaneous disc decompression for painful herniated disc revealed that while both treatments help patients in the short run, only disc decompression kept patients pain free up to two years later.
More...Strict Blood Sugar Control In Some Diabetics Does Not Lower Heart Attack, Stroke Risk
Article Date: 16 Dec 2009
Strictly controlling blood glucose levels in type 2 diabetics with long-term, serious coexisting health problems such as heart disease and hypertension does not lower their risk of a heart attack or stroke, according to a UC Irvine Health Policy Research Institute study.
More...
Note: This information has been developed and provided by an independent third-party source. World Medicine does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-company sources.
